Join
Live feed
·
PRReleasevia Quantisnow
Moleculin Biotech Inc. logo

Moleculin Appoints Leading Expert in Pancreatic Cancer to its Scientific Advisory Board to Support Development of Annamycin

ByQuantisnow·Wall Street's wire, on your screen.
MBRX· Moleculin Biotech Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MBRX (Moleculin Biotech Inc.) and more on Quantisnow.